STOCK TITAN

OCUL (NASDAQ: OCUL) holder files Rule 144 to sell 7,863 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A shareholder of OCUL has filed a notice of proposed sale under Rule 144 for 7,863 shares of common stock. The shares have an aggregate market value of $71,082.31 and are intended to be sold on NASDAQ around 02/12/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

The securities were acquired on 02/11/2026 as restricted stock vesting under a registered plan from the issuer, in the same amount of 7,863 shares, with no separate cash payment listed.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the OCUL Form 144 filing disclose about planned share sales?

The Form 144 discloses a plan to sell 7,863 OCUL common shares with an aggregate market value of $71,082.31. The planned sale is on NASDAQ around 02/12/2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

How were the OCUL shares in this Rule 144 notice originally acquired?

The 7,863 OCUL common shares were acquired on 02/11/2026 through restricted stock vesting under a registered plan from the issuer. The filing identifies the issuer as the source, and the nature of payment is listed as Not Applicable.

What is the aggregate market value of OCUL shares covered by this Form 144?

The filing shows an aggregate market value of $71,082.31 for the 7,863 OCUL common shares to be sold. This figure reflects the market value used for the notice and is tied to the proposed Rule 144 sale on NASDAQ.

Which broker is handling the proposed OCUL Rule 144 share sale?

The planned sale of 7,863 OCUL common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, listed at 1 New York Plaza, 8th Floor, New York, NY 10004. This broker is named as the intermediary for the NASDAQ transaction.

When are the OCUL shares described in the Form 144 expected to be sold?

The notice lists an approximate date of sale of 02/12/2026 for the 7,863 OCUL common shares. This date follows the 02/11/2026 restricted stock vesting and is the target timing for the Rule 144 sale on NASDAQ.

How many OCUL shares are outstanding in relation to this planned Rule 144 sale?

The filing reports 217,691,779 OCUL common shares outstanding as a reference figure. The planned Rule 144 sale covers 7,863 shares, providing context for the size of the proposed transaction relative to total shares outstanding.
Ocular Therapeut

NASDAQ:OCUL

OCUL Rankings

OCUL Latest News

OCUL Latest SEC Filings

OCUL Stock Data

1.99B
210.69M
3.33%
90.81%
7.95%
Biotechnology
Pharmaceutical Preparations
Link
United States
BEDFORD